What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Cardiology
Platelet, Internal medicine, Cell biology, Immunology and Surgery are his primary areas of study.
His Platelet study integrates concerns from other disciplines, such as Neutrophil extracellular traps, Fibrin, Pathology, Intravital microscopy and Thrombus.
His Internal medicine research includes themes of Endocrinology and Cardiology.
His Cell biology research incorporates themes from Endothelial stem cell, Biochemistry, Nitric oxide and Bone marrow.
His Immunology study combines topics from a wide range of disciplines, such as Pharmacology, Coagulation and Lymph.
His research investigates the connection between Stent and topics such as Myocardial infarction that intersect with problems in Angioplasty.
His most cited work include:
- 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). (1195 citations)
- Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo (942 citations)
- Thrombosis as an intravascular effector of innate immunity (759 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Cardiology, Platelet, Surgery and Cell biology.
His Myocardial infarction, Percutaneous coronary intervention, Clopidogrel, Prasugrel and Acute coronary syndrome investigations are all subjects of Internal medicine research.
Steffen Massberg combines subjects such as Clinical endpoint, Conventional PCI and Antithrombotic with his study of Percutaneous coronary intervention.
His work on Heart failure, Regurgitation, Coronary artery disease and Ejection fraction as part of general Cardiology study is frequently linked to In patient, therefore connecting diverse disciplines of science.
His Platelet research is within the category of Immunology.
The concepts of his Cell biology study are interwoven with issues in Endothelial stem cell, Endothelium and Bone marrow.
He most often published in these fields:
- Internal medicine (46.61%)
- Cardiology (37.86%)
- Platelet (19.91%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (46.61%)
- Cardiology (37.86%)
- Cardiogenic shock (5.91%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Cardiology, Cardiogenic shock, Heart failure and In patient.
His study in Myocardial infarction, Mitral regurgitation, Conventional PCI, Clinical endpoint and Prasugrel falls within the category of Internal medicine.
His Conventional PCI research is multidisciplinary, incorporating perspectives in Shock and Percutaneous coronary intervention.
His Cardiology study frequently draws connections to adjacent fields such as Mortality rate.
His studies deal with areas such as Anesthesia, Extracorporeal membrane oxygenation, Circulatory system and Refractory as well as Cardiogenic shock.
As a member of one scientific family, he mostly works in the field of Heart failure, focusing on Tricuspid valve and, on occasion, Regurgitation.
Between 2019 and 2021, his most popular works were:
- Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy. (106 citations)
- 5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves: Results From the CHOICE Randomized Clinical Trial (24 citations)
- Transcatheter Edge-to-Edge Tricuspid Repair for Severe Tricuspid Regurgitation Reduces Hospitalizations for Heart Failure (14 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Cardiology
His primary areas of study are Internal medicine, Cardiology, Heart failure, In patient and Pneumonia.
Internal medicine and Device failure are two areas of study in which Steffen Massberg engages in interdisciplinary work.
His Cardiology study frequently intersects with other fields, such as Mortality rate.
He has researched Heart failure in several fields, including Clinical endpoint and Tricuspid valve.
His study explores the link between Immunopathology and topics such as Lung that cross with problems in Immunology, Immune system and Innate immune system.
His study looks at the intersection of Disease and topics like Platelet with Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
